The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers regarding a recent publication that suggests a possible increased risk of death at two years and...
Stents Peripheral
Peripheral stents are used to open narrow and hardening arteries that supply blood to the legs and feet.
-
-
Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, explains...
-
Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System from the U.S. Food & Drug Administration (FDA). The device is approved for the treatment of...
-
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials presented at VIVA 2017 this week.
News | Peripheral Artery Disease (PAD) | January 17, 2019
January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter...
Technology | Stents Peripheral | October 05, 2018
October 5, 2018 — Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent...
News | Peripheral Artery Disease (PAD) | May 15, 2018
May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to...
News | Stents Peripheral | April 27, 2018
April 27, 2018 — Intact Vascular Inc. recently closed a Series C financing totaling $20 million. This financing is...
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.
Feature | Cath Lab | September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical...
News | Stents Peripheral | July 26, 2017
July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the...
News | Peripheral Artery Disease (PAD) | July 17, 2017
July 17, 2017 — LimFlow SA announced enrollment of the first patient in the U.S....
News | Stents Peripheral | July 14, 2017
July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an...
News | Stents Peripheral | April 28, 2017
April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world...
News | Stents Peripheral | March 16, 2017
March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris...
News | Stents Peripheral | March 02, 2017
March 2, 2017 — Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the...
News | Stents Peripheral | December 13, 2016
December 13, 2016 — Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18...
News | Stents Peripheral | December 08, 2016
December 8, 2016 — LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow...
